Al-driven applications enable a new era of intelligent engagement
BARCELONA, Spain–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/lifesciences?src=hash" target="_blank"gt;#lifescienceslt;/agt;–Veeva
Systems (NYSE:VEEV) today announced new capabilities in Veeva
Commercial Cloud to accelerate the industry’s move to intelligent
customer engagement. With the availability of its new artificial
intelligence (AI) application, Veeva
Andi, and embedded intelligence in Veeva
CRM and Veeva
Vault PromoMats, Veeva is delivering sophisticated AI-driven
applications so companies can engage more efficiently and effectively
with customers.
Veeva Commercial Cloud unifies customer engagement with multichannel
Veeva CRM; the right content and customer data with Veeva Vault
PromoMats and Veeva
OpenData; a next-generation commercial data warehouse with Veeva
Nitro; and artificial intelligence with Veeva Andi.
“We are committed to helping the industry drive the most efficient and
effective customer engagement with the right commercial foundation
powered by AI,” said David Logue, senior vice president of commercial
strategy at Veeva Europe. “Veeva Commercial Cloud helps companies
advance their commercial strategies and drive smarter, compliant
interactions with the right customers in the right channels.”
Intelligent capabilities and solutions now part of Veeva Commercial
Cloud will help advance the industry’s progress toward intelligent
customer engagement:
-
Veeva Andi is a new AI application that embeds tailored
insights and suggestions right in Veeva CRM. As part of the Veeva
CRM Suite, Veeva Andi makes it easy to adopt, deploy, and scale
AI. With the unique ability to control and manage AI, companies have
the power to deliver the right message in the right channel at the
right time for an improved customer experience. Veeva Andi used with
Customer Journeys—a new capability in Veeva CRM to better target and
manage customers through stages of an adoption lifecycle—helps
companies drive the best actions at the right customer stage. Veeva
Andi is available today in North America. Read today’s Veeva
Andi press release to learn more. -
Veeva CRM Approved Notes leverages AI to help field reps
build better customer relationships and remain compliant with every
interaction. The new capability makes it easy for field reps to
capture free text notes in Veeva CRM and use the power of AI to detect
potential compliance risks such as off-label messaging. Veeva CRM
Approved Notes is included Veeva CRM and planned for availability in
2020. -
Veeva Vault Auto Claims Linking is a new capability in
Veeva Vault PromoMats that will help improve speed and compliance of
content development. Vault Auto Claims Linking uses AI to suggest
links from claims to related references, reducing the administrative
burden and risk of managing claims across countries, channels, and
assets. Vault Auto Claims Linking is planned for availability by the
end of 2019.
In other news today, Veeva introduced new innovations in Veeva CRM,
including Veeva Approved Messaging, to advance compliance and digital
engagement in the life sciences industry. Read today’s Veeva
CRM press release to learn more.
To learn how Veeva Commercial Cloud enables intelligent customer
engagement, visit veeva.com/eu/CommercialCloud.
Registrations for Veeva
Commercial & Medical Summit Europe are now open. Join us in
Barcelona from 3-5 December 2019, where more than 1,200 life sciences
professionals will gather to hear the latest news and market trends in
the industry, experience innovative technology, and network and share
best practices.
Additional Information
Connect with Veeva on LinkedIn: linkedin.com/company/veeva-systems
Follow
@veeva_eu on Twitter: twitter.com/veeva_eu
Like
Veeva on Facebook: facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is the leader in cloud-based software for the global
life sciences industry. Committed to innovation, product excellence, and
customer success, Veeva serves more than 700 customers, ranging from the
world’s largest pharmaceutical companies to emerging biotechs. Veeva is
headquartered in the San Francisco Bay Area, with offices throughout
North America, Europe, Asia, and Latin America. For more information,
visit veeva.com.
Forward-looking Statements
This release contains forward-looking statements, including the market
demand for and acceptance of Veeva’s products and services, the results
from use of Veeva’s products and services, and general business
conditions, particularly in the life sciences industry. Any
forward-looking statements contained in this press release are based
upon Veeva’s historical performance and its current plans, estimates,
and expectations, and are not a representation that such plans,
estimates, or expectations will be achieved. These forward-looking
statements represent Veeva’s expectations as of the date of this press
announcement. Subsequent events may cause these expectations to change,
and Veeva disclaims any obligation to update the forward-looking
statements in the future. These forward-looking statements are subject
to known and unknown risks and uncertainties that may cause actual
results to differ materially. Additional risks and uncertainties that
could affect Veeva’s financial results are included under the captions,
“Risk Factors” and “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” in the company’s filing on Form
10-K for the period ended January 31, 2019. This is available on the
company’s website at veeva.com under
the Investors section and on the SEC’s website at sec.gov.
Further information on potential risks that could affect actual results
will be included in other filings Veeva makes with the SEC from time to
time.
Contacts
Roger Villareal
Veeva Systems
925-264-8885
roger.villareal@veeva.com
Kiran May
Veeva Systems
+44-796-643-2912
kiran.may@veeva.com